Global Immune Response Testing Market Global Report 2026 Market
Healthcare Services

Immune Response Testing Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Immune Response Testing Market From 2026 To 2030?

The immune response testing market has seen considerable expansion in recent years. Its value is anticipated to rise from $16.36 billion in 2025 to $18.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.6%. The historical expansion of this market stems from the increasing prevalence of immune-related disorders, wider use of antibody-based diagnostics, expansion of clinical immunology laboratories, growing adoption of ELISA testing methods, and increased vaccine response monitoring.

The market for immune response testing is projected to experience swift expansion over the coming years. This market is anticipated to reach $26.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the forecast period include a heightened demand for personalized immune profiling, the increasing application of immune monitoring in oncology and vaccine development, the broadening of point-of-care immune testing, the expanding incorporation of AI in diagnostic interpretation, and a greater emphasis on detecting immune dysfunction early. Key trends anticipated within the forecast period involve a greater uptake of multiplex immune assays, an increased utilization of cellular immune response analysis, the growing integration of automated testing platforms, the expansion of high-sensitivity diagnostic panels, and a reinforced focus on immune monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp

What Major Drivers Are Influencing Demand In The Immune Response Testing Market?

The increasing occurrence of autoimmune diseases is anticipated to boost the expansion of the immune response testing market moving forward. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own healthy cells and tissues. The rising incidence of these diseases is mainly attributed to heightened exposure to environmental pollutants, which can impair immune function and provoke immune assaults on the body’s own tissues. Immune response testing improves the management of autoimmune diseases by offering accurate information about the body’s immune activity, facilitating early detection and customized treatment strategies. It also aids in more effective disease surveillance and contributes to better patient results through precise adjustments in therapy. For example, in February 2024, as per Arthritis Australia, an Australia-based non-profit organization, it is estimated that 562,378 Australians will be living with RA in 2025, constituting 14% of all arthritis cases that year. By 2040, this figure is forecast to grow by 33% to 748,721 people. This signifies an increase of 186,343 Australians with RA compared with 2025. Consequently, the growing prevalence of autoimmune diseases is fueling the growth of the immune response testing market.

Which Segments Are Included In The Analysis Of The Immune Response Testing Market?

The immune response testing market covered in this report is segmented –

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing

2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing

2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis

3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays

4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

How Are Trends Impacting The Immune Response Testing Market?

Leading companies in the Immune Response Testing market are prioritizing the development of innovative solutions, such as immune profiling technologies, to meet the increasing demand for advanced diagnostics in post-viral syndromes and for adaptive immunity assessment. These immune profiling technologies are designed for a comprehensive analysis of the immune system, evaluating both cellular and humoral responses, which provides more detailed insights compared to traditional serological tests that primarily detect antibody levels. For instance, in April 2024, Virax Biolabs Group Limited, a UK-based biotechnology company, unveiled its portfolio of immune profiling solutions at ESCMID Global 2024, specifically targeting the evaluation of adaptive immunity in post-viral conditions. These solutions integrate advanced assays, including multi-parametric flow cytometry and targeted biomarker panels, enabling the precise characterization of immune cell subsets and functional responses. Key features include high sensitivity, customizable panels for diverse post-viral syndromes, and seamless integration with digital reporting platforms for simplified data interpretation. Their applications span from clinical research to personalized patient monitoring, offering benefits such as the early detection of immune dysfunction and support for therapeutic decision-making.

Which Key Industry Participants Are Active In The Immune Response Testing Market?

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA

Read the full immune response testing market report here:

https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Immune Response Testing Market?

North America was the largest region in the immune response testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immune Response Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27314&type=smp

Browse Through More Reports Similar to the Global Immune Response Testing Market 2026, By The Business Research Company

Nanomaterials Global Market Report

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanosilica Global Market Report

https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report

Nanofibers Global Market Report

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model